(EMAILWIRE.COM, February 05, 2019 ) Metabolomics Market is a powerful and unique analytical approach for the systematic identification and quantification of small-molecule metabolites, metabolite target analysis, metabolic profiling, and metabolic fingerprinting in various biological systems and samples.

This market majorly comprises detection techniques such as mass spectrometry (MS) and nuclear magnetic resonance spectroscopy (NMR), and separation techniques such as gas chromatography. These techniques are used in metabolome studies, primarily in toxicology testing and developing personalized medicine.

Download PDF:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=900

Key Market Trend;

Growing use of hyphenated technologies are liekly to provide largest growth opportunity for metabolomics market players
Over the past four years, a number of hyphenated systems have been launched by market players. A hyphenated technology is a combination of two or more analytical tools.

Hyphenated technologies reduce cost by requiring the installation a single instrument. They also provide ease of operation and require lesser space as compared to the installation of two or more standalone devices. In addition, these technologies have broadened the applications of analytical techniques in the analysis of biomaterials, especially natural products.

Prominent players in the global metabolomics market:

Thermo Fisher Scientific (U.S.), Agilent Technologies (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), and Shimadzu Corporation (Japan). Other leading players in this market include Bio-Rad Laboratories (U.S.), Bruker Corporation (U.S.), Biocrates Life Sciences AG (Austria), Human Metabolome Technologies Inc. (Japan), LECO Corporation (U.S.), and Metabolon Inc. (U.S.). A majority of the leading players in this market are based in developed countries across North America and Europe.

Read More in Detailed: https://www.marketsandmarkets.com/Market-Reports/metabolomics-technology-market-900.html